- Advanced Micro-Fab reported a net income of 1.62 billion yuan for the fiscal year.
- The company’s total revenue for the same period was 9.07 billion yuan.
- Market analysts are optimistic about the company’s performance, with 36 buy recommendations.
- There are 2 hold recommendations for Advanced Micro-Fab.
- No analysts have issued a sell recommendation for the company.
A look at Advanced Micro-Fabrication Equ Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 5 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts studying Advanced Micro-Fabrication Equipment Inc. are optimistic about the company’s long-term outlook, as indicated by its solid Smartkarma Smart Scores. With a growth score of 4 and resilience and momentum scores of 5 each, the company seems well-positioned for future success. This suggests that Advanced Micro-Fabrication Equ is likely to experience strong growth in the coming years and has the ability to withstand economic challenges. However, its value and dividend scores of 2 each imply that investors may need to evaluate other aspects of the company’s performance before making investment decisions.
Advanced Micro-Fabrication Equipment Inc., based in China, specializes in manufacturing micro-fabrication equipment for the semiconductor and related high technology industries. The company conducts research, development, production, and sales of semiconductor equipment, catering to the evolving needs of these sectors. With its promising growth, resilience, and momentum scores, Advanced Micro-Fabrication Equ appears to be on a positive trajectory for the future, positioning itself as a key player in the semiconductor equipment market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars
